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Abstract 
Background 
The HIV epidemic continues to be a major problem in sub Saharan Africa. Nearly 70% 
of the world's HIV- 1 seropositive individuals live in sub Saharan Africa 1. Several factors are 
thought to be unique to the HIV epidemic in sub Saharan Africa. The prevalence is higher than 
other parts of the world, clinical co infections are seen frequently, women are infected at higher 
prevalence rates in comparison to men and the disease progresses more rapidly 2. Of the 
different co infections that occur among HIV - 1 seropositive individuals, genital ulcer disease 
(GUD) has been shown to be associated with HIV- 1 infection 3. It is thought that GUD 
increases infectivity, transmissibility and acquisition of HIV - 1. GUD is also of concern since 
its prevalence in sub Saharan Africa continues to rise. Understanding the relationship between 
HIV- 1 infection and GUD could help create policies which may more effectively contain and 
reduce the spread of the HIV- 1 pandemic. 
Methods 
A systematic review was performed to evaluate the current body ofliterature regarding 
GUD co infections among adult females in sub Saharan Africa with HIV- 1. It was 
hypothesized that a higher prevalence rate ofGUD would be seen among females of lower SES 
and younger age groups. Additionally, analysis was conducted using a secondary data set of371 
Malawians who were followed for 13 months. Univariate analyses were conducted to calculate 
prevalence rates ofGUD. Bivariate analyses were conducted to assess differences in GUD 
prevalence by gender and HIV status using Chi-square tests. Kaplan Meier survival time models 
were used to calculate incidence rates for GUD. It was thought that higher rates ofGUD would 
be seen among women and HIV- 1 seropositive individuals. 
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Results 
Within the Malawian cohort that was studied, the incidence rate for GUD among men 
was 5.33 cases per 100,000 person years while the incidence rate among women was 20.12 cases 
per l 00,000 person years. The incidence rate of GUD among HIV - l seropositve and 
seronegative individuals was 8.98 cases per 100,000 person years and 8.02 cases per l 00,000 
person years, respectively. Among individuals who were HIV- l seropositive, 3,811 clinical 
diagnoses were made in the l3 month period while l ,983 
Interpretation 
Among this Malawian cohort, it appears that the incidence rate of GUD among women is 
higher and that among men. Additionally, HIV- l seropositive individuals were given more 
clinical diagnoses compared to HIV- 1 seronegative individuals. 
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Introduction 
Among HIV - 1 seropositive individuals in sub Saharan Africa, co infection with other 
diseases is an important problem. Co infections among HIV - I seropositive individuals can 
increase acquisition ofHIV -1, increase transmission ofHIV -1 as well as speed up progression 
of AIDS 2• The AIDS epidemic in sub Saharan Africa continues to persist and the highest 
incidence and prevalence rates are seen among young women of reproductive age 4. In the last 
decade, there has also been an increase in the prevalence of genital ulcer disease (GUD) in sub 
Saharan Africa. Evidence has shown that there may be an association between GUD and HIV-
1 infection 3 While several studies have looked at the association between GUD and HIV - 1 
among men, less literature exists to examine this relationship among women. With the 
increasing prevalence and incidence of HIV - 1 among women and the recent increase in GUD 
cases and HIV - 1 prevalence and incidence across sub Saharan Africa, more research should be 
done to understand the role ofGUD in the spread ofHIV- 1 among women in sub Saharan 
Africa. It is hypothesized that women oflower SES, education and age have higher prevalence 
proportions of both GUD and HIV. 
A systematic literature review of studies that examined the association between GUD and 
HIV- I infection among women in sub Saharan Africa was conducted. Additionally, data 
analysis on GUD and other clinical outcomes of HIV - I were performed among a cohort of 571 
Malawian individuals. The goal of the data analysis was to observe trends of GUD among the 
Malawian cohort over a 12 month period. Incidence rates ofGUD were compared between 
males and females and between HIV- I seropostive and seronegative individuals. Additionally, 
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a comparison of the diagnoses made for HIV- 1 seropositive and seronegative persons was 
made. 
Epidemiology of the AIDS Epidemic in Africa 
At the end of 2003, the global estimate of individuals living with HIV -1 was 
approximately 40 million people. It was estimated that 5 million of these cases were new cases, 
and that there were over 3 million deaths globally due to HIV -1 . Furthermore, of the 40 million 
HIV -1 positive individuals, 26 million of these people, or 65%, were living in Sub-Saharan 
Africa 1• Over 30% of the people in Botswana, Lesotho, Swaziland and Zimbabwe were .infected 
with HIV-1 at the end of2001. Namibia and Zambia had prevalences exceeding 20% while 
Malawi and Kenya's HIV-1 prevalence exceeded 15% 5 • 
In sub-Saharan Africa, females comprise 60% of those individuals infected with HIV-1. 
Furthermore, 75% of the females in sub-Saharan Africa who are infected are between the ages of 
15 and 24. This pattern of increased incidence and prevalence ofHIV-1 among women has been 
described as the "feminization" of the HIV-1 pandemic 6• 
Clinical Co infections Seen With HIV - I 
There are several features that make the AIDS epidemic in Africa unique in comparison 
to the epidemic in other parts of the world. To begin with, the prevalence of HIV- 1 infection in 
sub Saharan Africa is higher than it is anywhere else in the world. Secondly, women are affected 
7 
disproportionately. Also notable is that HIV appears to be transmitted more easily, the clinical 
manifestations seen among individuals are different and they progress more rapidly 2• 
Clinical co infections are of significant clinical importance because they increase HIV 
transmission, acquisition and they also increase the progression of disease among those with 
HIV/AIDS by increasing both infectiousness and susceptibility 7. 
Some of the more common clinical co infections seen among HIV -I infected 
individuals in sub Saharan Africa include bacterial infections, helminthic infections and 
protozoal infections. Bacterial infections associated with sexually transmitted infections (STis) 
include ulcerative organisms like Haemophilus ducreyi (chancroid), Treponema pallidum 
(syphilis) and HSV- 2. Nonulcerative bacterial STis include Neisseria gonorrhea and 
Chlamydia trachomatis. While non ulcerative STis are more prevalent than ulcerative STis, 
epidemiological evidence shows that ulcerative STis significantly increase the risk of acquiring 
HIV - I infection. Tuberculosis, caused by mycobacterium tuberculosis, is the most common 
opportunistic infection seen among HIV - I infected individuals worldwide 8 9 . Helminthic 
infections are also common in developing countries. These infections are oftentimes acquired 
during early childhood and persist into old age. Epidemiological studies have shown that in sub 
Saharan Africa, there is similarity between the geographical distribution of helminthic infections 
and HIV. This pattern has raised questions as to causal relationships between hehninthic 
infections and HIV. Protozoal infections often seen with HIV infection include Plasmodium 
falciparum malaria, Leishmaniasis and Trypanosomiasis. P. falciparum malaria, also associated 
with HIV - I infection, also has a high prevalence in sub Saharan Africa 2 10 . 
Diseases that concurrently infect individuals with HIV can change the course of HIV - I 
by weakening the immune system 2 Thus, it is important to understand the various clinical co 
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infections that can drastically affect both the clinical course, transmission and acquisition ofHIV 
- 1. Numerous studies have shown that sexually transmitted infections (STis) increase the risk of 
HIV- I transmission and acquisition 7• Genital ulcer disease (GUD) is a manifestation of several 
different types ofSTis. GUD is most commonly defined as a lesion on the surface of the skin 
caused by superficial loss of tissue with inflammation 11 • In sub Saharan Africa and throughout 
the world, the most common etiology of GUD is HSV- 2. Studies have shown that both HSV-
2 infection and HIV- 2 infection are on the rise in sub Saharan Africa. Accordingly, more cases 
of GUD have also been reported 12• For these reasons, it is important to understand associations 
between GUD and HIV - I infection. 
STis and the HIV Pandemic 
Of the clinical manifestations mentioned, STis are of special importance in considering 
the HIV pandemic in sub Saharan Africa. STis are "hyperendemic" in tropical Africa 13 • 
Additionally, they have the ability to increase both infectiousness of and susceptibility to HIV -I 
7
• Epidemiological evidence has shown that there is a strong association between STis and 
increased risk of acquiring HIV -I. In fact, it is the "epidemiological synergy" that has been used 
to explain the rapid spread of the HIV -1 pandemic within certain populations like sub Saharan 
Africa 14• The spread ofHIV-1 in sub Saharan Africa has primarily been through heterosexual 
contact 15 • Thus, it has commonly been hypothesized that the rapid spread of HIV -I in sub 
Saharan Africa can be explained by the presence of sexually transmitted diseases, especially 
. I I d. 3 16 gemta u cer 1sease . 
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What is known about GUD and HIV - 1 Infection 
Genital ulcer disease (GUD) is most commonly defmed as a lesion on the surface of the 
skin caused by superficial loss of tissue with inflammation 11 • The lesions can be caused by a 
number of different etiologic agents. In developing countries, GUD is most cormnonly caused 
by Treponema pallidum, Haemophilus ducreyi, herpes simplex virus type 2 (HSV-2) and HSV-1 
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In the 1980's, epidemiologic studies conducted in South Africa showed that chancroid 
and syphilis were the major causes of GUD and represented 70- 90% of cases of GUD 11 . 
However, in the 1990's, the prevalence ofGUD due to Herpes began to increase in Africa and 
today HSV-2 is the leading cause of genital ulcer disease worldwide 18 19. In some areas of sub 
Saharan Africa with alarming numbers of HIV -1 infected individuals, HSV -2 prevalence rates 
among women are as high as 75% 12 • 
A study by Ping et al. showed that persistent inflammation in areas of ulceration can lead 
to increased numbers of CD4+ lymphocytes, target cells for HIV - 1. In effect, the presence of 
CD4+ lymphocytes promote the acquisition ofHIV- 1 in HIV- l negative, HSV-2 positive 
individuals who are exposed to HIV - l 3. Studies have shown that heat inactivated HSV 1 and 
HSV2 increased HIV-1 expression in macrophages by induction ofNF- Kb 20 These studies 
confirmed that in persons infected with GUD or other STDs and HIV - 1, there is an increase in 
HIV- 1 load, particularly in genital lesions, semen or in both 21 7 . These finding support more 
effective transmission of the virus from those with STDs and HIV - l seropositivity to those 
without HIV - l. In terms of infectiousness, a study by Ping et al. found that co infection with 
STDs and HIV - l may elicit a more infectious HIV - l variant 22 Additionally, ulcerations and 
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mucosal lesions decrease both physical and mechanical barriers which allows for easier access of 
HIV into the bloodstream 23 • 
In summary, genital ulcer disease results in areas of ulceration that have increased HIV-
1 load making transmission to an HIV- 1 seronegative individual more likely. Additionally, 
persons with genital ulcerations are at increased risk for acquiring HIV - 1 since areas of 
inflammation around the ulcer bed are targets for HIV - 1 and since ulceration causes a 
breakdown of skin which normally serves as a protective barrier. Additionally, co infection of 
an STI and HIV- I may result in a more infectious HIV- 1 variant. 
What Has Been Shown About STis and HIV- 1 -Existing Studies 
Cross Sectional Studies 
While studies in molecular biology have demonstrated that the presence of HSV- 2 can 
increase HIV- 1 replication, studies in humans have also shown clear associations between 
GUD and HIV- 1. The following studies showing associations between HIV- 1 and GUD are 
all cross sectional. Although cross sectional studies do contribute to the current body of 
knowledge, they are limited because they cannot show temporality. 
In a cross sectional study of 418 lower socioeconomic strata prostitutes in Nairobi by 
Simonsen et a!., significant associations were found between HIV seropositivity and younger 
age, use of oral contraceptives (OR= 1.8, CI 95% = 1.1 - 2.9, p < 0.05) and GUD (OR= 3.2, p < 
0.00001). One limitation of this study was that genital ulcers were only cultured for 
Haemophilus species 24 Another cross sectional study of 1233 prostitutes in the Democratic 
Republic of the Congo by Nzila et a!. showed that HIV- 1 positive women had a higher 
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prevalence ofGUD compared to HIV- I seronegative individuals (9 versus 3%, p < 0.001), 
were less likely to use condoms in their sexual encounters (9 versus 15%, p = 0.009) and 
reported more frequent use of antibiotics to prevent STDs (55 versus 42%, p = 0.001 ). Ulcers 
were cultured for H. ducreyi and HSV and dark field microscopy was performed 25. 
Cohort Studies 
Cohort studies are more useful than cross sectional studies because they allow subjects to 
be followed over a set period of time and temporal associations can be made. A prospective 
cohort study by Martinet al. followed 779 FSWs in and STD clinic in Mombasa Kenya 
examining the associations between STD' s, HIV and OCPs. GUD was significantly associated 
with HIV -I infection 26. 
A retrospective cohort study conducted by Gray et a!. in Rakai, Uganda, attempted to 
calculate the probability of HIV -I transmission per coital act and how various factors influenced 
infectivity. The study participants were HIV-1 discordant, monogamous couples ranging in age 
from 15 years old to 59 years old. Only couples who were monogamous, with only one person 
in the couple being HIV-1 positive were included in the study. 174 couples who met the 
inclusion criteria were enrolled to be in the study for the duration of four years. Results from 
this study showed that the probability ofHIV-1 transmission per sexual act was higher ifGUD 
was reported by the HIV-1 positive partner than if it was not. (0.0041 vs 0.0011; p=0.02). The 
higher probability of transmission among those with ulceration was seen at all viral loads. 
Additionally, the rate ratio of transmission was lower for HIV-1 positive men compared to HIV-
1 positive women but the difference was not statistically significant. This study also showed that 
the risk ofHIV transmission among younger people aged 15-29 was higher compared to 
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persons aged 35-59. Another important fmding was that the probability of transmission per act 
increased significantly with HIV viral load 27• 
Some of the limitations of this study include the small sample size of 17 4 couples. The 
reported probability of the overall transmission per coital act in the Rakai population was 0.0011. 
This probability is comparable to the range of 0.0001-0.0020 seen in European, north American 
and Thai heterosexual couples. However, since the sample size was small and the cultural norm 
may not be having a monogamous relationship, this probability may not be generalized to the 
Ugandan population. Another limitation of this study may be the fact that reporting or recall bias 
could be present. The data gathered is based on interviews with individual patients. Since 
individuals may not have felt comfortable reporting the details of their sexual encounters or may 
have forgotten details about various sexual encounters, this could lead to reporting bias 27. 
Another retrospective cohort study by Gray et a!. based on the Rakai cohort examined 
determinants ofHIV-lload. The cohort consisted of256 subjects ranging in age from 15 to 40 + 
with both incident and prevalent HIV infections. The retrospective cross sectional cohort study 
conducted in the Rakai District in Uganda by Gray eta!. showed that individuals with prevalent 
HIV infection and symptomatic GUD had higher viral loads than HIV prevalent individuals 
without GUD. This is an important finding because it has significant implications for 
transmission ofHIV. That is, individuals with GUD have high viral loads and are more likely to 
transmit the virus to another person during sexual intercourse. Furthermore, there was increased 
viremia in persons with recent seroconversion and among those with incident HIV infection, 
viremia was highest in persons 25-29 years old. Additionally, the prevalence ofHSV -2 in 
females was found to be 74.3% and 59.6% in males. HSV-2 seropositivity was associated with 
higher HIV viremia in those subjects with incident HIV infection but not prevalent HIV 
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infections 21 • This finding is important given that a previous study showed that HSV-2 was the 
main etiology of GUD within the Rakai population 21 . 
Additionally, a stUdy by Obasi showed that HSV-2 infection starts at an earlier age in 
women. The same study also showed that HSV-2 infection was significantly associated with a 
history of genital ulcer disease 28 29. 
A retrospective cohort study by Simonsen et aL looked at HIV infection among lower 
socioeconomic strata prostitutes in Nairobi, Kenya. The study included 418 prostitutes in 
Nairobi living in one lower socioeconomic residential section of Nairobi. The study found that 
there was a significant association between HIV seropositivity and GUD (OR= 3.32, p < 
0.00001) and also younger age. Another interesting finding in this study was the association 
between women who were HIV seropositive and OCP 24. 
Addendum for Masters Paper 
HIV Background Information 
Human Immunodeficiency Virus (HIV) is a retrovirus classified as a member of the 
genus Lentivirus and the family Retroviridae. Lentiviruses are single stranded, positive- sense, 
enveloped RNA viruses. They contain reverse transcriptase allowing the viral RNA genome to 
be converted to double-stranded DNA subsequent to entry within the target cell 30• 
HIV causes acquired immunodeficiency syndrome (AIDS). AIDS is a debilitating health 
condition wherein the immune system begins to fail leading to potentially life threatening 
opportunistic infections. HIV is transferred from person to person via blood, semen, vaginal 
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fluid, pre- ejaculate or breast milk. The major modes of transmission whereby HIV is 
transmitted from one person to another include unprotected sexual intercourse, contaminated 
needles and transmission from an infected mother to her baby at birth or through breast milk 31 . 
There are two species ofHIV that can infect humans: HIV- 1 and HIV- 2. It is thought 
that HIV - I originated in southern Cameroon after being transmitted from wild chimpanzees to 
humans. HIV- 2 on the other hand, is thought to have originated from they Sooty Mangabey, an 
Old World Monkey found in Guinea- Bissau, Gabon and Cameroon 32• HIV- 2 has decreased 
pathogenicity compared to HIV- I. It is transmitted less efficiently than HIV - I and it 
establishes a slower disease progression due to lower viral loads. All of these factors may help 
explain the pandemic distribution of HIV - 1. In contrast, HIV - 2 has an endemic distribution 
and is mostly limited to West Africa. However, there has been growing concern for increasing 
prevalence of HIV - 2 in certain parts of Europe, most notably Portugal, as well as southwestern 
. fl d" 32 regwns o n 1a . 
Genital Ulcer Disease in the HIV Seropositive Individuals 
The course of GUD in patients with HIV -I is different from that seen in patients without 
HIV-1. Studies have shown a delay in ulcer healing in persons who have HIV- I seropositivity 
33 Other studies revealed that persons with HIV -1 seropositivity and GUD had larger sores 
compared to those patients who were HIV -I negative with GUD 34• Additionally it has been 
shown that GUD is consistently associated with a higher HIV - 1 load in subjects with incident 
and those with prevalent infection 21 • 
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GUD and HIV Epidemic and Women 
The trend in suh Saharan Africa of women showing higher prevalence and incidence 
rates of HIV - I infection has been termed the feminization of HIV 6. There are several 
biological and psychosocial explanations to account for this growing pattern. 
Additionally, several markers serve as reliable predictors of female vulnerability to HN -
I infection. Some of these factors include poverty, cultural norms, violence and certain legal 
issues and access to information and services and biological factors. 
It is important to understand the biological mechanisms that make women more 
susceptible to HIV -I infection. Susceptibility to HIV -1 varies throughout the course of a 
woman's reproductive life. Adolescent girls seem to be the population that is most vulnerable to 
HIV-1. Biologically, younger women have immature physiologic properties such as cervical 
ectopy and exposed columnar cells provide easier targets for HIV-1 6. It is thought that higher 
levels of progesterone which are found during pregnancy, cause women to be more susceptible 
to HIV -1 infection. Equally important is the fact that 20- 45% of infants born to HIV - 1 
positive mothers in the African setting also become infected with HIV - I. Pregnant women who 
are HIV- 1 seropositive can pass the virus to their children during the intrauterine, intrapartum 
or breastfeeding periods 35 • Additionally, it has been shown that it is easier for HIV to be 
transmitted to women in comparison to men. 
Table I 36• 
Estimated per act risk for acquisition ofHIV -1 
by exposure rout.,Jlll · 
Exposure Route 
Estimated infections.per 
I 0,000 exposures to an 
infected sourc_e 
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Blood Transfusion 
3olill 
6.5= 
I Insert:ive fellatio • 
Behavioral Factors and HIV Infection in Women 
In addition to biological factors that increase HIV -1 infection among women, several 
behavioral mechanisms have also been proposed. It is thought that the use of hormonal 
contraceptives and the presence of STDs may lead to increased HIV susceptibility in women. A 
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study by Sagar et a!. showed that use of hormonal contraceptives by women could accelerate the 
progression ofHIV but the exact mechanism of this interaction is not known 37• Additionally, 
younger women are more likely to engage in high risk sexual behaviors. Some of these risky 
behaviors include unprotected sex, injection drug use, commercial sex as well as limited 
empowerment 6. 
While biological and behavioral mechanisms ofHIV infection and transmission are 
important, it is also important to consider psychosocial phenomenon. In Sub Saharan Africa and 
across the globe, these factors have a profound effect on the feminization of the HIV-1 
pandemic. Because cultural norms and attitudes control how individuals behave, these factors 
often dictate behavior in a sense. In fact, studies have shown a strong link between HIV -I 
infection among women and cultural norms that influence power in interpersonal relationships 38. 
There are many different types of cultural norms which may influence personal 
relationships which in effect drive patterns ofHIV infection. For example, in some societies, 
gender norms mandate that females remain ignorant and subordinate in sexual relationships. 
This practice can propagate the idea that only men should be educated and informed. Thus 
women remain ignorant of certain basic information regarding their own health. Thus, they are 
not able to make well informed decisions about factors that will affect their lives. Additionally, 
limited empowerment perpetuates economic and emotional dependence by females on males. 
This situation leads to power differentials wherein women have limited ability over their own 
bodies and are not able to make decisions regarding their own health. Equally important is the 
fact that women often bear the responsibility for care giving. Women who are solely caregivers 
have limited participation in economic activities including education thus constricting both social 
and economic opportunities 38 
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Systematic Review of the Literature 
A systematic review of the literature was conducted to show that among individuals in 
sub-Saharan Africa with low SES, low education levels, women of a younger age group are more 
likely than men to have genital ulcer disease and to be HIV seropositive. 
Selection of Articles 
In order to identifY the relevant literature for this paper, the MEDLINE database was 
searched in March and April2007. The following MeSH terms were used in the search: "Genital 
Diseases, Female/epidemiology"[MeSHJ and hiv and subsaharan Africa. Further more, the 
search was limited to individuals ranging in age from 13 to 80+ years old and to studies in 
English. Linda Collins, the UNC Health Sciences librarian, was also consulted to ensure that the 
search terms were broad enough. 432 studies resulted from the initial search. 
Abstracts of each of the articles from the initial search were reviewed. The articles 
selected from the initial pool of studies were selected based on selection criteria. The selection 
criteria included studies that were looking at genital ulcer disease and HIV - 1 in both men and 
women or women only in sub Saharan Africa. However, studies focusing only on men with no 
women were excluded. The studies that only focused on women involved female sex workers. 
An attempt was made to search for studies that involved male sex workers so that comparisons 
could be drawn between the two populations. However, no studies involving male sex workers 
were identified. Case reports and editorials were excluded. Additional studies were included 
based on the references from each of the studies selected. 
Appraisal of the Literature: Genital Ulcer Disease Among Women in sub Saharan Africa 
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
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Internal Validity Ratings 
Table 1 presents ratings for the various articles which have been classified based on the 
study design. Most of the studies pertaining to this topic are cross sectional although there are 
some cohort studies and some randomized control trials . 
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
Selection of Study Population 
The target population of this study was women ranging in age from 13 - 80+ years old. 
The only studies that focused exclusively on women looked at female sex workers and were 
included in the systematic review. Efforts were made to identify studies focusing on male sex 
workers in order to compare the populations of female and male sex workers. However, no 
studies involving male sex workers were identified. Since comparisons were being drawn 
between men and women, studies including both men and women were also included. However, 
those studied that only focused on males were excluded from the study. 
Measurements 
Various studies utilized different measurements in their studies. Whether or not the paper 
made specific mention oflab test and interview questions that were used in the study was noted. 
Most of the studies that were given a good rating included specific information on tests 
used to determine HIV serostatus and presence of HSV - 2, Treponema pallidum, Haemphilus 
ducreyi and Lymphogranulum venerum. In addition, the study by Simonsen et al. included a 
physical examination that included a vaginal speculum exam and a bimanual exam. The study 
also included a thorough sexual history. 
Both studies by Gray et al. described that to detect HIV, RT- PCR, ELISA and Western 
Blot were conducted. For detection ofHSV- 2, Treponema pallidum and Haemophilus ducreyi, 
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multiplex PCR was usedc. Additionally, the studies thoroughly described specific interview 
questions that were used in the study .. 
Other studies were lacking in their description oflab tests conducted. The study by 
Mwansasu et al. described techniques used to detect HSV at great lengths. However, it was not 
mentioned what or if tests were conducted to test for HIV serostatus. Additionally, several 
patients were thought to have ulceration due to syphilis however no tests were done to confirm 
this diagnosis. This was a major flaw of this particular study. In a study by Morgan et al, no 
testing was done to determine the etiology ofGUD. Additionally, the diagnosis ofGUD was 
made based on asking the patient whether they thought that they had GUD. 
Statistical Analysis and Confounding 
The quality of analysis of each study was based on whether appropriate statistical 
methods whether or not confounding was adjusted for. 
Results 
Association Between GUD and HIV 
Several studies in the systematic review showed that there was some association between 
genital ulcer disease and HIV- 1 infection. The meta analysis by Wald and Link showed a 2.2 
RR (95% CI, 1.4- 3.2) ofHIV acquisition in persons with HSV- 2. The Gray study showed 
that the probability of transmission of HIV- 1 was greater among those with GUD (0.0041) 
compared to those without GUD (0.00 11, p = 0.02). The Mwansasu study showed that there was 
an association between HIV- 1 and GUD however the exact relationship was unclear. The 
Kamya study showed that there was an association between HIV - 1 serostatus and the particular 
size of an ulcer. Persons infected with HIV- 1 were found to have larger ulcers. Studies 
involving only female sex workers also found associations between HIV- 1 and GUD. Sh1dies 
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done earlier in the 1980's usually found H. ducreyi or Treponema pallidum to the be most 
common cause ofGUD. However, in the late 1990's the more common cause ofGUD was 
found to be HSV- 2. 
Comparison Between Males and Females 
While most studies were not able to show significant differences among men and women, 
the Ahmed study was able to do this. The study showed that women with HSV- 2 were more 
likely to be HIV- infected than men (60% versus 39%, p = 0.006). No studies that looked at 
only female populations were available unless the population was female sex workers. For men, 
the opposite was true. There were studies involving exclusively men from the general 
population but no studies only looking at male sex workers were available. The Martin and 
Nzila studies, both involving female sex workers, showed associations between GUD and HIV-
1 infection. Both studies also showed association between HIV seropositivity and use of oral 
contraceptive pills. The Martin study showed as association between use of high dose oral 
contraceptive pills and HIV- 1 acquisition (HR, 2.6; CI, 0.8- 8.5). 
Association Between GUD and HIV and other Sociobehavioral Factors 
In studies involving female subjects, several interesting factors arose. The study by Todd 
et a!. showed that HIV status in women was associated with never having given birth (OR 4.11 
95% CI 1.47- 11.5) and women who are married to HIV- positive spouses (OR= 34, 95% CI 
5.77- 200). Another trend seen among women and described by Martinet a!. was the 
association between use of high- dose oral contraceptive pills and HIV- 1 acquisition. (HR, 
2.6; CI, 0.8 - 8.5). The In the cross sectional study of 1233 prostitutes in Kinshasa, Nzila et a!. 
attempted to show various factors associated with HIV infection. Results of the study showed 
that HIV positive women had a higlier prevalence of GUD (9 versus 3%, p < 0.00 I). 
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Additionally, there was an independent association shown between HIV seropositivity and 
persons ranging in age from 26- 30, regnlar use of oral medications, presence of genital ulcer, 
antibody to H. ducreyi and cytological evidence ofHPV on PAP smear. 
Summary of Internal Validity 
Articles tbat were studied in this particular systematic review was fair to poor. In most of 
the studies, participants were selected from either STD clinics or from a hospital setting. This 
factor affected the internal validity of tbe study by creating selection bias. That is, the study 
population characteristics would be drastically different from those of the general population. 
Additionally, studies that utilized information from patient interviews were subject to recall bias. 
All patients were not likely to be able to remember their exact sexual histories and furthermore, 
some patients may not have been comfortable revealing this information. An additional flaw in 
the cross sectional studies is a lack of ability to control for confounding factors such as sexual 
behavior, age and other factors. Another issue among cross section studies is being able to 
determine causality. Whether HIV infection causes GUD or whether GUD causes HIV infection 
is not able to be closely examined within a cross sectional study. 
External Validity of Findings from the Systematic Review: Generalizability to Malawi 
Population 
The external validity of tbe findings from the systematic review as they could be 
generalized to the people of sub Saharan Africa are fair to poor. Most of the subjects from these 
studies were recruited from either STD clinics, hospitals or were part of special populations 
including female sex workers. Because the prevalence and incidence rates of STis are most 
likely much higher among all of the above mentioned populations, it would not be accurate to 
generalize these findings to the general population . 
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
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Table 2. Final Appraisal of the Literature Table 
• 
Study Study Title Study Source Measurements Significa 
Author Design Population nt Results 
I Wald and Risk of Human Meta HSV-2-
Link lnununodeficiency Analysis positive 
Virus Infection in individua 
Herpes Simplex Virus Is had 
Type-2 Seropositive twice the 
Persons: A Meta- risk of 
analysis acquiring 
HIV 
compared 
to HSV-
2-
negative 
individua 
I 
2 Gray et al. Determinants of HIV- Retrospecti 256 subjects RT-PCR HIV load 
I Load in Subjects ve cross (116 males, HSV -2lgG increased 
with Early and Later sectional 140 females) ELISA m 
HIV Infections, in a cohort from the rural Western Blot subjects 
General-Population analysis Rakai district with 
Cohort ofRakai, of Uganda GUD, 
Uganda subjects 
with 
GUD 
during 
the 
interval 
ofHIV 
acquisitio 
nhad 
higher 
loads of 
H!Vthan 
those 
without 
GUD 
(4.71 vs. 
4.32), 
HSV-2 
seropositi 
vity more 
common 
in 
females 
(80%) 
than in 
males 
(56.9%), 
HIV-1 
transmiss 
ion~4 
24 
times 
higher for 
subjects 
with 
genital 
ulcers 
compared 
to those 
without 
3 Gray Probability ofHIV -I Retrospecti 174 HIV- RT-PCR Transmis 
transmission per coital ve cohort discordant ELISA SIOn 
act in monogamous, study monogamous Western Blot probabilit 
heterosexual, HIV -I- couples from Patient y 
discordant couples in Rakai, Uganda Interview increased 
Rakai, uganda (174 men, 174 from 
women) .0001 per 
act at 
viral 
loads< 
1700 
copies/m 
L to 
0.0023 
per act at 
38500 
copies/m 
Lor 
more (p ~ 
0.002) 
and were 
0.0041 
with 
genital 
ulceratio 
n versus 
0.0011 
without 
(p ~ 0.02) 
4 Mwansasu Detection ofHSV-2 Cross 69 people (50 HSV-2 42%HIV 
in genital ulcers from sectional males, 19 specific IgG E positive, 
STD patients in Dar females) Unclear how 52.5% 
es Salaam, Tanzania presenting with HIV was women 
genital ulcers tested and 38% 
selected from of men 
an STD clinic Associati 
in Dares on 
Salaam between 
HIV and 
HSV-2 
exists but 
IS 
unclear. 
5 Kamya The High Prevalence Cross 100 ELISA for 36% of 
of Genital Herpes sectional consecutive HIV antibody subjects 
Among Patients With patients with detection, had 
Genital Ulcer Disease GUDin Western Blot herpes 
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in Uganda Mugalo RPR, VDRL genitalis 
Hospital (most 
(Uganda) STD common 
clinic between STD? 
December diagnosis 
1990 and ) 
January 1991 HIV 
(73 men, 27 infection 
women), 57% maybe 
HIV positive associate 
d with 
larger 
lesions in 
patients 
with 
herpes 
Herpetic 
ulcers not 
associate 
dwith 
seropositi 
vity 
8 Simonsen HIV infection among Retrospecti 418 female RPR, TPHA 62%of 
lower socioeconomic ve cohort prostitutes in ELISA, the 
strata prostitutes in study Nairobi living Western Blot women 
Nairobi in one lower were HIV 
socioeconomic seropositi 
residential ve 
section of Significa 
Nairobi nt 
associatio 
ns found 
between 
HIV 
seropositi 
vity and 
Tanzania 
n orgigin 
(OR~ 
2.12, Cl 
95%~ 
1.18-
3.81, p < 
0.03), 
younger 
age, 
shorter 
duration 
of 
prostituti 
on, 
reduced 
fecundity 
, use of 
OCPs 
(OR~ 
26 
1.8, CI 
95%~ 
1.1- 2.9, 
p< 0.05), 
GUD 
(OR~ 
3.32, p < 
0.00001) 
1 Ahmed Etiology of Genital Cross Patients at two PCR of genital HIV 
Ulcer Disease and sectional STD clinics in ulcer specimen infection 
Association With Tanzania ( 48 Rapid latex rates 
Human women and 54 agglutination among 
Immunodeficiency men) test for HIV, GUD 
Virus Infection in ELISA patients 
Two Tanzanian Cities were 
46% and 
52% in 
Dares 
Salaam 
and 
Mbeya; 
among 
the non-
GUD 
patients 
the rates 
were 
35% and 
45%, 
HIV 
infection 
rate in 
womenm 
Dares 
Salaam 
higher 
than that 
in men, 
women 
with 
HSV-2 in 
Dares 
Salaam 
were 
significan 
tly more 
likely to 
be HIV-
infected 
than men 
(60% 
versus 
39%; p<, 
~ 0.006) 
1 Morgan Genital Ulceration in 102 patients No labs Rates of 
Rural Uganda (48 women available for GUD are 
27 
and 54 men) diagnois of four 
withGUD in genital ulcers times 
Tanzania and no higher 
mention of among 
what participa 
techniques nts 
usedforHIV infected 
testing withHN 
compared 
to those 
who are 
HIV 
negative 
I Todd Risk Factors Case 92 cases, 903 ELISA HIV 
Influencing HIV control controls Questionnaire status in 
Infection Incidence in nested selected from Data women 
a Rural African within an 12 rural abstraction associate 
Population: A Nested RCTof communities in from chart d with 
Case-Control Study treatment of Mwanza, review never 
syndromic Tanzania having 
sexually given 
·transmitted birth (OR 
infections 4.11 95% 
CI, 1.47 
- 11.5), 
he 
incidence 
ofHIV 
infection 
was 
significan 
tly 
associate 
d with 
GUS (OR 
~ 2.71, 
95%CI 
1.32-
5.54), 
high risk 
of 
infection 
in women 
married 
to HIV-
positive 
spouse 
(OR~ 
34,95% 
CI 5.77-
200), in· 
women, 
no 
associatio 
n 
between 
28 
incidence 
ofHIV 
infection 
and 
reported 
syndromi 
c STI, 
HSV-2 
was the 
most 
important 
RFfor 
HIV 
infection 
showing 
a65% 
PAPin 
men and 
a 59% 
PAPin 
women. 
I Serwadda Human Nested Case 132 female and HIVEIA GUDis 
Immunodeficiency Control 116 male Western Blot increased 
Virus Acquisition Study subjects HerpSelect 2 during 
Associated with matched with ELISA IgG HIV 
Genital Ulcer Disease 264 female and seroconv 
and Herpes Simplex 232 male ersion 
Virus Type 2 subjects from and after 
Infection: A Nested rural Rakai HIV 
Case-Control Study in District in acquisitio 
Rakai, Uganda southwestern nand this 
Uganda IS seen 
mainly 
among 
HSV-2 
positive 
individua 
Is. 
I Nzila HIV and other Cross 1233 Darkfield H. 
sexually transmitted sectional prostitutes microscopy ducreyi 
diseases among study from different performed for was the 
female prostitutes in geographic GUD,no most 
Kinshasa areas of mention of common 
Kinshasa HSV test cause of 
EIA for HIV GUD 
ELISA (38% of 
Western Blot cases) 
followed 
by herpes 
simplex 
virus 
(12%), 
GUD 
more 
common 
among 
29 
HIV 
positive 
women 
(9 versus 
3%,p< 
0.001), 
independ 
ent 
associatio 
n with 
HIV 
seroposit 
vity: 26 
to 30 
years old, 
regular 
use of 
oral 
medicatio 
n, 
presence 
of genital 
ulcer, 
antibody 
to H. 
ducreyi 
on 
cytologic 
evidence 
ofHPV 
on PAP 
smear 
I Martin Hormonal Prospective 779 female sex Interview Trend for 
Contraception, cohort study workers in Physical exam associatio 
Sexually Transmitted Mombasa, HIV -I ELISA n 
Diseases, and Risk of Kenya Western Blot between 
Heterosexual attending STD KOH use of 
Transmission of clinic microscopy high-
Human Gram's stain dose oral 
Immunodeficiency EIA contracep 
Virus Type 1 tive pills 
andHIV 
-I 
acquisitio 
n(HR, 
2.6; CI, 
0.8 -
8.5). 
I Ghys The associations Prospective 1201 female EIA Among 
between cohort study sex workers in RPR 609 HIV 
cervicovaginal HIV Abidijan, Cote TPHA -I 
shedding, sexually d'lvoire from a Western Blot seropositi 
transmitted diseases confidential ELISA ve 
and clinic for women, 
nnmunosuppresswn female sex HIV -I 
in female sex workers workers shedding 
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in Abidjan, Cote was more 
d'Ivore frequent 
Ill 
imrnunos 
uppresse 
dwomen 
(AOR 
6.3; 95% 
CI, 3.4-
11.9, 
AOR2.9; 
95% CI, 
1.6-5.0 
forCD4 
< 14% 
andCD4 
< 14-
28% 
versus 
CD4> 
28%) and 
mwomen 
with a 
cervical 
or 
vaginal 
ulcer 
(AOR 
3.9; 955 
CI 2.1-
7.4) 
I Lag a Condom Promotion, 531 initially GUDwas 
Sexually Transmitted HIV -I a risk 
Diseases Treatment negative factor for 
and Declining female sex HIV -I 
Incidence of HIV -I workers seroconv 
Infection in Female erswn 
Zairian Sex Workers 
Table 3. Final Quality Ratings Table. Each study was rated 0-3 for each category, with 
O=poor, I =fair, 2=good, 3=excellent 
·····························································~················· a. Cross - Sectional Studies 
31 
Kamya 
Ahmed 
Morgan 
Nzila 
Simonse 
n 
Serwadd 
a 
3 
3 
3 
3 
2 
3 2 
2 2 
1 2 
1 2 
0 0 
0 2 3 13 
2 1 1 11 
0 1 1 8 
0 1 1 8 
0 2 3 7 
32 
Manuscript Section 
Introduction: The HIV I AIDS Epidemic and Genital Ulcer Disease in Malawi 
The HIV I AIDS pandemic poses a major health concern throughout the world and 
particularly in sub Saharan Africa where both prevalence and incidence are extremely high. In 
the southeastern African nation of Malawi, HIV I AIDS is a leading cause of death. In 2003 it 
was estimated that 87,000 of the nation's 12 million people died from AIDS and that there were 
110,000 new infections 39 40. 
Studies have shown that those infections which are concurrent with HIV - 1 can increase 
both the transmission and acquisition ofHIV- 1 7 It has also been suggested that infections 
concurrent with HIV- 1 may further compromise and individual's immune system due to 
chronic immunosuppression. Furthermore, immunosuppression can lead to higher viral loads 
levels. Immunosuppression combined with increased HIV- !loads accelerate an individual's 
progression towards AIDS and the accompanying clinical manifestations 41 . Of the various co 
infections that occur among HIV - 1 seropositive persons, GUD is of particular concern. The 
incidence and prevalence of GUD in sub Saharan Africa and in Malawi are high 11 42 . 
F h d. h h · · b GUD d HIV l · , · 21 2s 21 43-47 urt ermore, stu 1es ave s own assoc1ahons etween an - m1ect10n · ' . 
Understanding the patterns and etiology of GUD could be instrumental in helping to 
control the HIV I AIDS epidemic in sub Saharan Africa and throughout the world. With a better 
knowledge of the exact association between GUD and HIV- I, more effective treatment 
protocols can be created to reduce prevalence and incidence of both conditions. 
In this retrospective cohort study in rural Malawi, the incidence rates of GUD between 
men and women as well as HIV - 1 seropositive and seronegative individuals are examined. 
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Additionally, diagnoses among HIV- 1 seropositive and seronegative individuals are compared. 
Methods 
Study Setting and Population 
A secondary data analysis was conducted using an existing data set that was compiled in 
a prospective cohort study conducted during 2000-2001. Potential participants (N = 2,383) 
were recruited from a tea estate in Thyolo District, Malawi through an HIV screening process 
whereby HIV- 1 serostatus was determined by a series of rapid diagnostic assays. After the 
initial screening, 656 (27%) were individuals were found to be HIV - 1 seropositive, 171 0 (72%) 
were HIV- 1 seronegative and 17 (1 %) were missing information on HIV- 1 serostatus. 
Subjects who had clinical AIDS - defining features, a history of tuberculosis or who could not 
commit to remaining in the area for the following 9 months were excluded from the study. 
Additionally, adults who were determined to be febrile at baseline (sublingual temperature> 
3 7.4 C) were either excluded or their emollment was postponed until they were asymptomatic. 
569 (24%) of those persons initially recruited to be in the study consented to participate in the 
study and agreed to remain in the study area for 9 months 10• 48 . 
Data Collection 
Outcome Variable Measurements 
All persons enrolled in the study were required to attend a series of clinic visits and were 
monitored from October 2000 to November 2001. In addition to the baseline visit, required 
follow-up visits included a routine visit every eight weeks, interim visits when sick and visits 3, 
7, 14 and 28 days after administration of malaria medication. At enrollment (baseline visit), 
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demographic information was collected and CD4 counts were measured for all participants. At 
all subsequent visits, medical history and physical examinations were conducted; blood samples 
were taken to measure CBCs, detect malaria parasites and to determine HIV- l RNA 
concentrations. Plasma HIV- 1 RNA levels were measured by polymerase chain reaction at the 
Malawi- Liverpool Wellcome Laboratories. 
Measurement of Genital Ulcer Disease and Other Clinical Outcomes (Patient Oriented 
Outcomes) 
The outcomes of interest in this study were GUD and other clinical diagnoses among 
individuals in the cohort as detected over a 12 month period. GUD was broadly defined to 
include the following diagnoses : Genital Ulcer Disease (GUD), Sexually Transmitted Infection 
(STI), GUD follow up visits, Chancroid, Herpes Genitalia, Herpes Simplex, Pubic Sores, Penal 
Sores, Syndromic Syphilis defined by the classical clinical symptoms commonly associated with 
primary, secondary and tertiary forms of syphilis, Syphilis, Syphilitic Sores, Syphilis and Anal 
Sores. For the purposes of this study, subjects with positive RPR test results alone were 
considered to have syphilis but were not placed in the GUD category. For subjects with a 
negative RPR at baseline but subsequent positive RPR test during the 12 month study period, a 
variable called new RPR was created. Eventually, the GUD variable and the new RPR variable 
were combined. 
All clinical diagnoses made during the 12 month study period were recorded and 
categorized according to diagnoses made among persons who were HIV - 1 seropositive and 
those who were HIV- 1 seronegative. 
Measurement of Co variates (Disease Oriented Outcomes) 
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Patient names and identifier numbers were stored in the database. For the purposes of 
this study, data was de identified in order to protect the privacy of the patients involved in the 
study. However, at baseline visits, information including the patient's gender, age, marital 
status, HIV serostatus and whether or not condoms were given to the subject were all recorded 
and stored in a database. 
Statistical Analysis 
For the purposes of this study, identifiers such as names and medical record numbers 
were removed from the data set in order to protect the patients' privacy. Analysis of data was 
conducted using Stata (version 9; Stata Corporation). GUD was broadly defined to include the 
following diagnoses : Genital Ulcer Disease (GUD), Sexually Transmitted Infection (STI), GUD 
follow up visits, Chancroid, Herpes Genitalia, Herpes Simplex, Pubic Sores, Penal Sores, 
Syndromic Syphilis defined by the classical clinical symptoms commonly associated with 
primary, secondary and tertiary forms of syphilis, Syphilis, Syphilitic Sores, Syphilis and Anal 
Sores. 
Three separate outcome variables were created which included 1.) GUD 2.) incident 
syphilis based on RPR- positivity and 3) GUD and incident syphilis based on RPR- positivity. 
In Malawi, the diagnosis of GUD and the different diagnoses falling under the diagnosis of GUD 
is made based on clinical symptoms. RPR tests are based on lab results and give a presumptive 
diagnosis of syphilis. In this cohort, the RPR test was not conducted on any individuals with the 
diagnosis of GUD. Thus, the combined variable of GUD and new RPR cases was simply a sum 
of incident GUD cases and incident RPR positive test results. 
Univariate analyses were conducted to calculate prevalence of GUD, RPR positive tests, 
and the combined GUD and RPR positive variable. Bivariate analyses were conducted to assess 
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differences in GUD prevalence by gender and HIV status using Chi-square tests. Differences 
were considered statistically significant if the p -value associated with the Chi - square test was 
less than 0.05. Kaplan Meier survival time models were used to calculate incidence rates 
separately for: the three definitions of GUD: GUD, RPR- positivity and for GUD including new 
RPR positives. 
Results 
Table 4. Selected Characteristics for a Cohort of Adults in Thyolo District, Malawi (N= 571) at 
Baseline 
The characteristics of a cohort of 571 Malawian individuals were examined at baseline 
(Table 1). In this study sample there were 311 (45.53%) males and 260 (54.47%) females. Most 
individuals were between 18-34 years old. Nearly one third of the study population (n = 180) 
was 18- 24 years old and 36.65% of individuals (n = 21 0) were in the 25 - 34 year old age 
range. 68 or 11.87% individuals were in the 45+ age range. Most individuals in this cohort were 
married (77.41 %) while only 9.28% of the individuals were single and 8.06% were divorced and 
20 or 3.50% individuals were widowed. Among the 569 individuals tested for HIV- 1 at 
baseline, 64.50% were HIV- 1 seropositive while 35.50% were seronegative. HIV- 1· 
serostatus results were either missing or not reported for two individuals. 
Table 5. Prevalence of Syphilis (based on RPR seropositivity) by Sex Among All Visits Made 
Through Duration of Study 
Cases of syphilis were defined as visits where a subject had a positive RPR test. 
Of the 5,668 visits that occurred through the duration of the study, 2,951 RPR results were 
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positive resulting in a prevalence of 52.06% for syphilis (based on RPR positivity). There were 
2, 717 ( 4 7.94%) negative RPR test results. 
RPR status at baseline was also examined by gender. There were more males with 
syphilis (bases on positive RPR test) compared to females (p = 0.0001). 2,982 (89.68%) male 
visits were found to have syphilis at baseline (based on a positive RPR test) while 23 (0.96%) 
female visits were found to have syphilis (based on positive RPR test result). There were more 
female visits without syphilis (based on negative RPR test) compared to males visits without 
syphilis (p < 0.0001). 2,367 (99.04%) female visits did not have syphilis compared to 337 
(10.32%) of male visits who did not have syphilis. 
RPR status at baseline was also examined by HIV serostatus. Among those with HIV 
seropositivity, there were more visits with cases of syphilis (RPR positive test) compared to 
visits made by HIV seronegative subjects. Of those who were HIV seropositive, 2,919 (85.90%) 
visits were made where the subject had syphilis (based on RPR positive test). In contrast, there 
were 479 (14.10) visits were made wherein HIV seronegative individuals had syphilis (based on 
positive RPR test). Among HIV seronegative individuals, there were more visits with no cases 
of syphilis. Among HIV seronegative individuals, 32 (1.42%) visits were made where subjects 
were found to have syphilis. Among HIV seronegative individuals 2,225 (98.58%) visits were 
made where the subjects were not found to have syphilis. 
Table 6. GUD Incidence Defined by GUD, RPR Positivity or GUD and Incident RPR Positivity 
by Sex 
Incidence rates for GUD, GUD and new RPR positive individuals and for RPR were 
calculated. Females had a higher GUD incidence rate of 20.12 cases per 100,000 person weeks 
compared to males who had an incidence rate of5.33 cases per 100,000 person weeks. The 
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incidence rates for GUD and new RPR positive individuals were much higher among men. 
Males had an incidence rate of 133.25 cases per 100,000 person weeks while females had an 
incidence rate of 20.12 cases per 100,000 person weeks. The incidence rate for RPR positivity 
was also higher among males compared to females. Males had an incidence rate of 127.92 cases 
per 100,000 person weeks. No incident cases ofRPR positivity were observed among women 
during the study period. 
Table 7. Prevalence of Syphilis (determined by RPR Serostatus) by HIV Serostatusfor Visits 
Made During 12 Month Study Period 
Incidence rates for GUD, GUD and new RPR positive individuals and for RPR were 
calculated by HIV serostatus. GUD incidence rate among both HIV seropositve and 
seronegative subjects were similar. The incidence rate among HIV seropositive subjects was 
8.98 cases per 100,000 weeks and 8.02 cases per 100,000 weeks for HIV seronegative 
individuals. Incidence rates for GUD and new RPR positive were much higher in HIV 
seropositive individuals (p = 0.0001). The HIV seropositive group had an incidence rate of 
134.67 cases per 100,000 person weeks while HIV seronegative persons had an incidence rate of 
8.01 cases per 100,000 person week. For RPR positivity alone, the incidence rate among HIV 
seropositive individuals was much higher at 125.69 cases per 100,000 person weeks while no 
cases were found among HIV seronegative individuals. 
Table 9. Comparison of Diagnoses Among HIV Seropositive and Seronegative Individuals 
A comparison between the diagnoses among individuals who were HIV seropositive and 
seronegative was made. HIV seropositive individuals had 3,811 diagnoses compared to HIV 
seronegative individuals who had 1,983 diagnoses. The most frequent diagnosis among HIV 
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seropositive and seronegative individuals was musculoskeletal pain. Other diagnoses that were 
frequent among those with HIV seropositivity included upper respiratory tract infection, back 
ache and body pain. Diagnoses that were frequently reported among HIV seronegative patients 
included fever of unknown origin, body pains and malaria. 
Table 4. Selected Characteristics for a Cohort of Adults in Thyolo District, Malawi 
(N=571) at Baseline 
Characteristic N (%) 
Gender 
Male 311 45.53 
Female 260 54.47 
Age (Years) 
18-24 180 31.41 
25-34 210 36.65 
35-44 115 20.07 
45 + 68 11.87 
Marital status at enrollment 
Married 
442 77.41 
Single 53 9.28 
Separated 10 1.75 
Divorced 46 8.06 
Widowed 20 3.50 
HIV Serostatus 
Positive 367 64.27 
Negative 202 35.38 
Missing data 2 0.35 
Condoms Given 
Yes 64 11.21 
No 461 80.74 
Missing data 46 8.06 
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Table 5. Prevalence of Syphilis (based on RPR seropositivity) by Sex Among All Visits 
~ade of 
Positive 
Negative 
Total 
Visits Made by Males 
with Positive RPR 
Visits Made by Males 
with Negative RPR 
Visits Made by 
Females with Positive 
RPR 
2,951 52.06 
2,717 47.94 
5,668 100 
2,982 89.68 
337 10.32 
23 0.96 
Visits Made by 
Females with Negative 
RPR 
2,367 99.04 
Table 6. GUD Incidence Defined by GUD, RPR Positivity or GUD and Incident RPR 
Sex 
95% Confidence Interval P value 
Iocident Rate 5.33 cases/100,000 
Among Men person weeks 
Incident Rate 20.12 cases/1 00,000 
Among Females person weeks 
Incident rate 2.11 per I 00,000 -0.0000418, -4.28 e "-07 
difference person weeks 
Incident rate ratio 0.2649177 0.0817794,0.8360376 
of men to women 
Prev frac ex 0.7350823 0.1639624,0.9182206 
Prev frac pop 0.5642486 
Pearson chi square 
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test for Difference 
by Gender 
Incident Rate 
Among Men 
Incident Rate 
Among Females 
Incident rate 
difference 
Incident rate ratio 
of men to women 
Prev frac ex 
Prev frac pop 
Pearson chi square 
test for Difference 
by Gender 
Incident Rate 
Among Men 
Incident Rate 
Among Females 
Incident rate 
difference 
Incident rate ratio 
of men to women 
Prev frac ex 
Prev frac pop 
Pearson chi square 
test for Difference 
by Gender 
0.0001 
95% Confidence Interval P value 
133.25 cases/100,000 
person weeks 
0.0000287 or 20.12 
cases/1 00,000 person 
weeks 
0.0001616 0.0001271, 0.0001961 
6.622943 3.287967, 15.58231 
0.8490097 0.6958607, 0.9358247 
0.8118945 
0.0001 
95% Confidence Interval P value 
127.92 cases/100,000 
person weeks 
0 cases 
0.0001827 0.0001551,0.0002104 
0 13.6377 
1 0.9266738, 1 
1 
0.0001 
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Table 7. Prevalence of Syphilis (determined by RPR Serostatns) by HIV Serostatus for 
Made 12 Month 
Characteristic Prevalence 
HIV + with Positive 2,919 85.90 
RPR 
HIV- with Negative 479 14.10 
RPR 
HIV + with Positive 32 1.42 
RPR 
HIV - with Negative 2,225 98.58 
RPR 
95% Confidence Interval P value 
Incident Rate Among 8.98 cases per 
HIV Seropositive 100,000 person 
weeks 
Incident Rate Among 8.02 cases per 
HIV Seronegative 100,000 person 
weeks 
Incident rate 1.37 e" 06 -0.0000135, 0.0000162 
difference 
Incident rate ratio of 1.119997 0.3022515,6.184702 
men to women 
Prev frac ex 0.1071403 -2.308503,0.8383107 
Prev frac pop 0.0857122 
Pearson chi square 
testfor Difference by 
Gender 0.0001 
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95% Confidence Interval P value 
Incident Rate Among 134.67 cases per 
HIV Seropositive 100,000 person 
weeks 
Incident Rate Among 8.01 cases per 
HIV Seronegative 100,000 person 
weeks 
Incident rate 0.0001809 0.00015, 0.0002119 
difference 
Incident rate ratio of 16.79995 5.657365, 82.22885 
HIV +toHIV-
Prev frac ex 0.940476 0.8232393, 0.9878388 
Prev frac pop 0.9250584 
Pearson chi square 
test for Difference by 
Gender 0.0001 
95% Confidence Interval P value 
Incident Rate Among 125.69 cases per 
HIV Seropositive 100,000 person 
weeks 
Incident Rate Among 0 cases per I 00,000 
HIV Seronegative person weeks 
Incident rate 0.0001796 0.0001524, 0.0002067 
difference 
Incident rate ratio of 12.61232,. (exact) 
men to women 
Prev frac ex 1 0.9207124, 1 
Prev frac pop I 
Pearson chi square 
test for Difference by 
Gender 0.0001 
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Table 9. Comparison of Diagnoses Among HIV Seropositive and Seronegative Individuals 
45 
46 
47 
Swallow Pain 1 0 
Thnnbhroid 1 0 
Tongue Sore 1 0 
Trauma 7 0 
Vitamin Deficiency 0 1 
Rltinf 1 0 
Pruritis 0 4 
Prbdsr 1 0 
Para1agia 1 0 
Livprob . 1 0 
Loa 2 0 
Human Bite 1 0 
Hydrocoele 2 0 
Hernia 0 1 
Headache 37 346 
Fever of Unknown Origin 4 0 
Cut on Toe 0 1 
Total 66 353 
Discussion 
The incidence rate for GUD was almost three times higher among females compared to 
males. Females had a GUD incidence rate of20.12 cases/100,000 person weeks while males had 
an incidence rate of 5.33 cases/100,000 person weeks (p = 0.0001). With an incident rate ratio of 
0.265, men are only 26.5% as likely as women to get GUD. While these results show clear 
differences in GUD incidence rates between men and women, no other studies that compared the 
incidence rates of GUD among men and women were found. 
GUD and New RPR Positives 
The incidence rate for GUD and new RPR positive individuals was 20.12 cases/100,000 
person weeks for females and 133.25 cases/100,000 person weeks for men. The pattern ,seen 
between men and women in this case differs drastically compared to that seen for GUD alone. 
That is, men have much higher incidence rates than women (p = 0.0001 ). The incident rate ratio 
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for GUD and new RPR positive individuals is 6.62 making men 6.62 times as likely to get GUD 
or a positive RPR test. 
RPR Positive Tests 
Males had an RPR incidence rate of 127.92 cases/! 00,000 person weeks while among the 
females, there were no new RPR positive test results. The high number of new RPR positive test 
results among men while no new cases are seen among females is interesting and alarming. One 
explanation for this could be that females in the cohort had prevalent cases of syphilis. That is, 
their cases already existed. Studies have shown that T. pallidum infection in sub Saharan Africa 
as well as in countries such as Malawi have began to decrease over the last decade 49. The 
decrease in cases ofT. pallidum most likely reflects several aggressive programs over the past 
decade which have supported empiric treatment of syphilis. While the incidence rate among this 
cohort of men is higher than it is among women, it would be interesting if this rate has decreased 
in comparison to what is was five years ago. 
Comparing Diagnoses o( HIV Seropositive and HIV Seronegative Individuals 
Comparison of the different diagnoses made for HIV seropositive and HIV seronegative 
individuals showed that there were more diagnoses made for HIV- I seropositive individuals. 
For Dermatologic diagnoses, HIV- I seropositive individuals had 44 different types of 
diagnoses while those who were HIV - I seronegative had a total of 9 different diagnoses. 
Among HIV- I seropositive individuals, rashes and pruritic rashes were the most common 
diagnose. Anti- retro virals (ARV s) are often associated with skin rashes. In fact, Abaca vir 
causes a hypersensitivity reaction in 5% of adults and children. Among GI diagnoses, the 
diagnosis of abdominal pain was the most frequent in both HIV- I seropositive and 
seronegative individuals. Among the HIV- I seropositive group, the diagnoses of dysentery and 
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gastroenteritis were quite common while this was not seen among the HIV - 1 negative 
diagnoses. Many of the ARVs that the HIV -1 seropositive patients must take have GI side 
effects. Several of the Nucleoside Reverse Transcriptase Inhibitors have GI side effects. These 
include Stavudine which causes GI disturbances, Lamivudine which causes abdominal pain and 
diarrhea and Didanosine which causes diarrhea, abdominal pains as well as nausea and vomiting. 
Some Non Nucleoside Reverse Transcriptase Inhibitors also cause diarrhea including Abacavir 
and Nevirapine. Other areas where there were striking differences in diagnoses was in the 
Cardiovascular diagnoses. HIV - 1 seronegative individuals had 167 complaints of chest pain 
compared to 14 complaints among HIV- 1 seropositive individuals. Additionally, under ID 
diagnoses, HIV - 1 seropositive individuals had more diagnoses of Malaria. This finding is 
consistent with previous studies that show that HIV- 1 infected adults living in malaria endemic 
regions have a high risk for malaria. Finally, in the OB/Genito- Uninary diagnosis section, HIV 
- 1 seropositive individuals had 198 diagnoses compared to 0 diagnoses for HIV - seronegative 
individuals. This finding is consistent with the hypothesis of this systematic review and with 
other studies that have been conducted. That is, sexually transmitted diseases which cause many 
of the OB/Genito Urinary diagnoses on the list like Urethritis, Orchitis, Pelvic Inflammatory 
Disease, Bartholinitis, can lead to or have manifestations of GUD leading to increases in HIV- 1 
transmission and acquisition. 
Limitations 
One limitation of this study was that cases with RPR positive tests were considered to 
have the diagnosis of syphilis. This definition of syphilis would overestimate the number of 
cases. The rapid plasma reagent test is a nontreponemal test These antilipoidal antibodies 
detected in this test are seen in other disease states such as pregnancy and after vaccination. 
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Therefore, these tests are not specific and they cannot be used to rule in disease. The RPR test 
has a sensitivity of 80% for patients with symptomatic primary syphilis and 100% sensitivity in 
patients with secondary syphilis. Positive RPR test results should be confirmed by treponema! 
tests which include the fluorescent treponema! antibody absorption (FTA- ABS) and the 
microhemagglutination assay (MHA- TP) forT. pallidum. Although these two tests can detect 
antibodies to other treponemes also, the T. pallidum antibodies are separated from other 
treponema! antibodies during a washing phase of the reaction 50• 51 . 
It is also important to consider that the RPR test takes a considerable amount of time to 
complete, interpretation of the test is subjective and experience is required to identify positive 
results 52• With these factors in mind, measurement bias may have been present with regards to 
RPR testing. Additionally, differences in the training ofhealthcare workers may have differed 
and all study subjects may not have been screened for syphilis equally. 
Aside from RPR, diagnoses that were made may vary from one clinical officer to another 
depending on their level of experience and comfort. 
Another limitation in this study was the study population. There were more men than 
women which could be one factor which may account for the higher incidence rate ofRPR 
among men compared to women. A search was done to compare syphilis prevalence or 
incidence between men and women in sub Saharan Africa but no such studies were identified. 
There may a disproportionate number of men who are infected with syphilis compared to women 
who are infected with syphilis. In fact, in the United States, studies have shown that the 
incidence of syphilis has been rising among men. Furthermore, in the United States in 2003, 
men having sex with men (MSM) accounted for 60% of total syphilis cases. 
Concluding Remarks 
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The data from this study shows that women in Malawi have a higher incidence rate of 
GUD compared to men. Additionally, the study shows that there are differences in the diagnoses 
for those who are HIV - I seropositive and for those who are HIV - I seronegative. Past studies 
have indicated that GUD is associated with HIV - I acquisition and transmission. In light of 
these findings, women should be targeted for GUD prevention as well as treatment. Both 
Reproductive and STD clinics should provide education, and condoms to all clients but women 
should be targets for these efforts. Additionally, further studies should be conducted to 
understand the etiology ofGUD among women in particular. 
Addendum 
Future Studies 
Most existing studies examining the relationship between GUD and HIV - I are cross 
sectional. Thus, they are not able to explore the issue of temporality. Cross sectional studies are 
not good at determining whether GUD results in increased HIV - I acquisition or whether HIV-
I acquisition results in an increase in GUD cases. Therefore, it would be beneficial if more 
prospective cohort studies could be conducted to look at GUD and HIV - I co infection. 
Additionally, there are no studies that examine female populations other than populations 
of female sex workers. While the sex industry is quite large in sub Saharan Africa and is very 
important in the spread of HIV - I, populations of females that are not sex workers should be 
studied. Thus, the results could be generalized to the population at large. 
Additionally, there were several interesting points that arose from some of the studies in 
the,systematic review and would merit further investigations. One point of interest in the 
Simonsen et a!. article was a paradoxical trend among female sex workers. It was noted that 
there was a decline of HIV prevalence with increasing duration of prostitution. That is, women 
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who had exposure to a greater number of sexual encounters and more men who were HIV - I 
seropositive were found to have a decrease in HIV - I prevalence. The two explanations for this 
phenomenon was that women were resistant to HIV - I, or that they were seroverters 24 53 . This 
phenomenon should be further investigated by conducting additional studies. The information 
could be used in the development of vaccines or other therapies for HIV- I. 
Another factor of interest was that 2 prospective cohort studies found positive 
associations between DMPA, injectable high dose progestin, and HIV- I. Several theories have 
been suggested to explain this including decreased use of condoms by these women, 
contaminated needles for the birth control injection and misclassification of contraceptive status 
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• While all of these explanations seems plausible, further studies should be conducted to 
examine the cause for this pattern that was noted in two studies. 
Treatment 
The control and treatment ofHIV is linked to sexually transmitted infections (STis). Numerous 
studies have shown that STis increase the infectivity and transmissibility ofHIV. However, 
there is still a large amount of stigma associated with STis which makes their treatment very 
difficult 11 • 
Negative attitudes associated with STis are linked to low self esteem, feelings of guilt 
and uncleanliness from having paid for sex. The stigma carried from having an STI oftentimes 
further delays individuals from seeking care and treatment. In fact, it is common for patients to 
seek care from traditional healers before going to a clinic or a hospital. While traditional 
remedies are viewed as being the best treatment by those who seek traditional treatment, no " 
studies prove their efficacy or effectiveness. To address the problem of STis and stigma, it 
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would be beneficial for each country to implement programs specific to its own cultures and 
beliefs. 
While individuals play a large role in whether they seek care for STDs or not, more 
robust efforts should be made to improve access to STI specialists who are well trained. In 
Africa, many STI specialists work in the private sector and are not available in public clinics 11 • 
Furthermore, the large scale, public health efforts to reduce STis has been geared towards either 
mass treatment or syndromic treatment ofSTis. An example of mass treatment for STis can be 
noted in a study conducted in Rakai, Uganda. The Rakai study was a community based 
randomized control trial carried out in 56 rural communities grouped into ten clusters. The 5 
clusters which were randomly selected to be treated received directly observed treatment with 
highly effective single dose antibiotics every ten months. Additionally, those individuals with 
syphilis were treated with an intramuscular dose of penicillin. This trial was stopped 
prematurely because after three rounds of mass treatment, there was no effect on HIV -1 
incidence. A similar study in Mwanza, Tanzania, also attempted to test the theory of mass 
treatment. However, the approach to mass treatment in Mwanza was different compared to the 
Rakai study because in addition to treating patients with antibiotics, healthcare workers were 
trained, patients made regular visits to health facilities and village campaigns to improve 
treatment-seeking behavior were implemented. This strategy which was more expansive proved 
to be more effective because HIV-1 incidence was 38% lower in the intervention group than in 
the comparison communities 54• 
In comparing the treatment strategies and the results of the Mwanza and Rakai trials, it is 
important to consider the specific characteristics of each of the two epidemics. The epidemic in 
Rakai is at a mature, generalized stage with a stable prevalence of 16% within the study 
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population. In contrast, the prevalence ofHIV -1 in Mwanza was relatively low at 4%, but 
rising. Thus, mass treatment and education may be more useful in communities with lower 
prevalence rates. In fact, computer generated models show that as HIV epidemics mature and 
become more generalized, STD' s contribute less to HIV - 1 transmission 55 . 
Another barrier to the treatment of STDs, GUD in particular, is the lack of clinical 
examination confirming the presence of ulcers. A study in KwaZulu, South Africa showed that 
only 19% of patients in an STD clinic were offered physical examinations 56. 
Also important is that STI epidemiology varies geographically depending on what stage 
of the HIV epidemic a particular country may be in. For example, in the 1990's, syphilis and 
chancroid were thought to be the most common causes of GUD in sub Saharan Africa. Now, 
however, HSV - 2 is thought to be the most common cause of GUD in sub Saharan Africa. With 
this information, treatment could include helping educate patients on identifying herpetic sores. 
Yet another powerful component that factors into STI treatment is the politics behind 
policy that drives the creation of various guidelines. Although targeting high risk groups has 
been shown to be an important strategy, governments have failed to do this out of a fear of 
further stigmatization of certain groups. In sub Saharan Africa, all heads of states are men. 
Consequently, the male dominated leadership, with a puritanical view of sex, oftentimes, do not 
allow sexuality to be discussed openly. 
Models o(Success: The 100% Condom Use Programme in Thailand 
Thailand has been quite successful in reducing it's prevalence of HIV- I. This positive 
trend has been largely attributed to the 100% Condom Use Program. The program was created 
with the idea that one of the main modalities of rapid transmission of HIV- I in Thailand was 
through the commercial sex industry (CSI). An instrumental component of the 100% Condom 
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Use Program was acknowledging the vulnerabilities of commercial sex workers. Multiple 
factors contribute to their vulnerabilities. As women, they already have a substandard role in 
society; secondly, these women are financially dependent. They rely on their clients for income. 
Additionally, most of these women are uneducated and they work in an illegal profession, 
making it very difficult for them to feel entitled to having certain rights. All of these factors are 
extremely important in considering prevention programs. Furthermore, the Thai Ministry of 
Health did acknowledge these psychosocial issues in formulating their prevention program. 
Collaboration of STI clinics, brothels and police enforcement agencies was encouraged. 
When men would come to STI clinics with infections, they would tell healthcare providers what 
brothel they had been to. Police officers would then go to the brothels to distribute condoms and 
charge fines for not using condoms. Additionally, the Thai government essentially flooded the 
Thai population with condoms so that they were readily available. The drastic results of this 
program were seen when condom use rose from 15% in 1994 to more than 90% just five years 
later in 1994. Additionally, the annual incidence of STis at a national level dropped from 
400,000 cases per year before the program started to less than 15,000 cases per year since 2000. 
This yielded a reduction rate of more than 95% 57 
The successes of this program should be closely studied and incorporated into prevention 
programs in sub Saharan Africa. Some of the limitations may be a lack of infrastructure of well 
established STI programs. Thailand had the advantage of well established, government 
established STI programs which had been running for over 50 years. Another obstacle that some 
of the sub Saharan African countries may face is a lack of support from the government. For 
example, current Prime Minister of Zimbabwe, Robert Mugabe, has been in office since 1980. 
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However, he is not willing to collaborate with aid organizations making it difficult to create 
programs which would provide care and medicines to the people of Zimbabwe. 
Sociobehavioral Factors 
Current data clearly shows that women in sub Saharan Africa face a greater burden of 
suffering from the HIV- I epidemic in comparison to their male counterparts. The chains of 
socioeconomic oppression which prevent women from progressing as individuals and 
empowering themselves also drive the HIV - I epidemic on the African continent. The 
interaction of educational factors, cultural beliefs and economic hardships place women in sub 
Saharan Africa at a high risk for acquiring HIV 6• 38• 58. 
In many countries in sub Saharan Africa, marriage for women is universal. Data from 
Malawi shows that marital status is closely associated with HIV infection. Women who are 
widowed, divorced or separated have higher rates of infection (37%) compared to married 
women (26%). Women who have not ever been married have the lowest prevalence ofHIV 
infection (5%). Additionally, polygamy is still practiced in many countries throughout sub 
Saharan Africa. In Malawi, women in a polygamous union have an HIV prevalence of 16% 
while those in monogamous unions have an HIV prevalence of 12% 59. 
Another factor of significant importance driving the "feminization" of the HIV epidemic 
in sub Saharan Africa is the lack of employment opportunities for women. Unemployment rates 
among women are high and in Zambia, only 15% of women work in the formal sector compared 
to 85% of men who work in the formal sector. Additionally, women are less likely to receive a 
formal education compared to men making it less likely for women to be able to find economic 
opportunities. Given the lack of education and employment opportunities, women oftentimes 
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resort to commercial sex work. As commercial sex workers (CSWs), women are still dependent 
on men for financial income. Furthermore, their health is placed in the hands of men who 
oftentimes refuse to use condoms, further compromising the well being of these women 60. 
Cultural beliefs about sex also play an important role in the HIV epidemic in sub Saharan 
Africa. In many communities in Africa, it is believed that a man should have sexual intercourse 
when he feels the urge. This may or may not be with his spouse. Additionally, a widow is 
expected to be sexually available for the other men in her husband's deceased family. These 
practices further perpetuate the idea that a woman has no say in her sexual health again leaving 
women powerless 60. 
The combination of educational norms, cultural beliefs and a lack of economic 
opportunities for women magnifies the power differential between men and women in sub 
Saharan Africa. These inequities continue to demean and demoralize women, taking away their 
dignity and their ability to feel empowered. This setting is a breeding ground for the HIV 
epidemic and until women gain social mobility and power within their communities, the 
feminization of AIDS will persist. 
Models (or Changing Sociobehavioral Factors 
Poverty is the underlying cause behind several of the sociobehavioral factors driving the 
HIV epidemic in sub Saharan Africa and other countries around the world. Many women in sub 
Saharan Africa are driven to prostitution in desperate attempts to support themselves and their 
children. 
While efforts are being made to uplift the situation of women around the world, more 
should be done to eliminate these detrimental disparities. The Global Fund for Women is a 
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nonprofit grant making foundation whose primary goal is to advance women's rights worldwide. 
The foundation focuses on economic security, violence against women, education, health and 
leadership. The foundation has supported many innovative efforts to address the HIV pandemic, 
especially in sub Saharan Africa. 
The Rwanda Women's Network (RWN) is currently being supported by the Global Fund for 
Women. It is a national humanitarian Non- Governmental Organization whose mission is to 
improve the socio-economic status of women throughout Rwanda. The organization aims to 
serve all women, but especially those who are survivors of sexual and gender- based violence. 
RWN has three components including healthcare and support, education/awareness programs on 
human rights and legal procedures as well as socio-economic opportunities. In efforts to foster 
economic growth, women can access financial credit to develop small business. Women are also 
able to study business management and learn other useful skills that will promote economic 
independence. 
It is critical to promote and encourage initiatives that allow women to build skill sets to 
gain economic independence, educate themselves and in turn empower themselves. Part of the 
solution to the HIV pandemic lies in allowing people, especially women, to access to resources 
that will allow them to break free from the chains of poverty and other unhealthy patterns. 
Concluding Remarks 
In sub-Saharan Africa, females comprise 60% of those individuals infected with HIV-1. 
75% of the females in sub-Saharan Africa who are infected with HIV are between the ages of 15 
and 24. It has been well established that HSV - 2 is one of the major causes of GUD in the sub 
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Saharan population. Furthermore, it has also been established that GUD plays a role in HIV -I 
transmission. 
Epidemiological data shows that women in sub Saharan Africa bear a large burden of 
suffering with regards to the HN pandemic. While studies in men have shown that GUD can 
lead to increased infectivity and transmissibility of HIV, there is a need for more high quality, 
prospective studies to be conducted among populations of women. 
Women are a population of special importance in considering the HIV pandemic in sub 
Saharan Africa. In many cultures in sub Saharan Africa, women do not have the economic 
freedom to make their own choices. Thus, cultural norms and practices have created a gamut of 
psychosocial barriers for the general population of women. Women are often in positions where 
they do not have the choice to make decisions about their own health. For example, in many 
situations they many not be able to negotiate condom use or other safe sex practices with their 
partners. Additionally, women who are in economically challenging situations may resort to 
prostitution in an attempt to have some financial security. Prostitution often involves high risk 
practices which further compounds this risk of HIV infection and transmission. 
Encouraging both men and women to practice safer sex practices to prevent STDs will be 
helpful in trying to contain and reduce the spread of the HIV- I pandemic. Beyond these 
temporary measures, however, social justice and equality are the only long term answers to the 
problem of the HIV- I pandemic. When individuals feel empowered to make healthy choices 
and when they have the financial freedom to make decisions that allow them to move towards 
healthier lifestyles, true progress will be achieved. 
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